Homepharma

pharma

AbbVie Stock Valuation Is Appealing Due to Humira Challenges

AbbVie Stock Valuation Is Appealing Due to Humira Challenges

September 19, 2022

Analyst gives opinion on Restaurant Brands International’s new strategy to revive Burger King

September 14, 2022

Bristol Myers Squibb stock and SPPI increase on FDA approvals, CLVS increases by 15%, and TWTR decreases on the Musk saga

Bristol Myers Squibb stock and SPPI increase on FDA approvals, CLVS increases by 15%, and TWTR decreases on the Musk saga

September 14, 2022

Moderna Stock Is Trading Upwards as CEO Confirms Plans for Mrna Factory in Japan

Moderna Stock Is Trading Upwards as CEO Confirms Plans for Mrna Factory in Japan

September 14, 2022

Johnson & Johnson stock rose with the announcement of a $5 billion share buyback program and repeated profit targets.

September 14, 2022

MindMed Announces Compliance with Nasdaq Listing Requirements

MindMed Announces Compliance with Nasdaq Listing Requirements

September 14, 2022

Pfizer, Biontech, Moderna, Novavax to Gain in Passing of New Law

Pfizer, Biontech, Moderna, Novavax to Gain in Passing of New Law

September 12, 2022

The merger agreement with Catheter Precision drives a 37% increase in revenue for Ra Medical.

The merger agreement with Catheter Precision drives a 37% increase in revenue for Ra Medical.

September 12, 2022

Pfizer and BioNTech’s vaccine for COVID-19 for Children is approved by Canada.

Pfizer and BioNTech’s vaccine for COVID-19 for Children is approved by Canada.

September 9, 2022

Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference

Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference

September 9, 2022

« 1 … 7 8 9 10 11 … 16 »